Skip to main content
. 2022 Apr 6;100(7):e1522–e1532. doi: 10.1111/aos.15148

Table 1.

Prioritization criteria in the allocation of remaining ampoules of verteporfin in the Netherlands

Patients with 1 functional eye, or a maximum visual acuity of 20/40 Snellen equivalent in the other eye, and…
Choroidal haemangioma with subretinal fluid in the macula
Central serous chorioretinopathy with optical coherence tomography documented persistent subfoveal fluid, where the leakage point is not treatable with focal laser
Polypoidal choroidal vasculopathy with foveal intraretinal or subretinal fluid or foveal hard exudates, deteriorating despite 4‐weekly treatment with intravitreal anti‐vascular endothelial growth factor (VEGF) injections and despite switching to aflibercept. Not treatable with focal laser
Non‐inflammatory choroidal neovascularization with subfoveal intraretinal or subretinal fluid with a height of >200 μm or foveal hard exudates, deteriorating despite 4‐weekly treatment with intravitreal anti‐VEGF injections and despite switching to aflibercept. Not treatable with focal laser
Children under the age of 18 with a choroidal haemangioma with subretinal fluid in the macula

anti‐VEGF = anti‐vascular endothelial growth factor.